Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,491.36
    -1,731.75 (-3.45%)
     
  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Teva, three U.S. drug distributors reach opioid settlement - source

The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv

(Reuters) - Drug maker Teva Pharmaceutical Industries Inc <TEVA.TA> and the three biggest U.S. drug distributors reached a settlement on Monday to avoid a trial over their role in the opioid addiction crisis, a source said on Monday.

Distributors Mckesson Corp <MCK.N>, Cardinal Health Inc <CAH.N> and AmerisourceBergen Corp <ABC.N> were set to go to trial Monday morning, along with pharmacy chain Walgreen Boots Alliance Inc <WBA.O>.

The source did not say if Walgreen was part of the settlement.

(Reporting by Tom Hals in Wilmington, Delaware; editing by Jason Neely)